Gradient Investments’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16.4M Buy
45,254
+631
+1% +$216K 0.23% 130
2026
Q1
$15.7M Sell
44,623
-1,537
-3% -$548K 0.24% 123
2025
Q4
$15.1M Sell
46,160
-1,391
-3% -$441K 0.24% 125
2025
Q3
$13.4M Buy
47,551
+315
+0.7% +$91.4K 0.22% 129
2025
Q2
$13.2M Buy
47,236
+285
+0.6% +$80.7K 0.24% 125
2025
Q1
$14.6M Sell
46,951
-2,554
-5% -$754K 0.3% 100
2024
Q4
$12.9M Buy
49,505
+9,095
+23% +$2.7M 0.26% 115
2024
Q3
$13M Sell
40,410
-14,291
-26% -$4.67M 0.27% 118
2024
Q2
$17.1M Sell
54,701
-2,335
-4% -$686K 0.38% 81
2024
Q1
$16.2M Sell
57,036
-5,342
-9% -$1.56M 0.38% 98
2023
Q4
$18M Sell
62,378
-3,120
-5% -$850K 0.43% 72
2023
Q3
$17.6M Buy
65,498
+60,587
+1,234% +$15.1M 0.46% 59
2023
Q2
$1.09M Buy
4,911
+31
+0.6% +$7.19K 0.03% 174
2023
Q1
$1.18M Sell
4,880
-1
-0% -$245 0.03% 173
2022
Q4
$1.28M Buy
4,881
+6
+0.1% +$1.61K 0.04% 174
2022
Q3
$1.1M Buy
4,875
+715
+17% +$173K 0.03% 174
2022
Q2
$1.01M Sell
4,160
-59,537
-93% -$14.6M 0.03% 180
2022
Q1
$15.4M Buy
63,697
+1,775
+3% +$408K 0.4% 59
2021
Q4
$13.9M Buy
61,922
+6,084
+11% +$1.28M 0.35% 71
2021
Q3
$11.9M Buy
55,838
+5,862
+12% +$1.35M 0.33% 84
2021
Q2
$12.2M Buy
49,976
+3,447
+7% +$848K 0.36% 67
2021
Q1
$11.6M Buy
46,529
+4,084
+10% +$974K 0.38% 50
2020
Q4
$10.8M Sell
42,445
-584
-1% -$135K 0.46% 53
2020
Q3
$10.9M Sell
43,029
-326
-0.8% -$80.8K 0.46% 53
2020
Q2
$10.2M Sell
43,355
-4,153
-9% -$948K 0.47% 61
2020
Q1
$9.63M Buy
47,508
+298
+0.6% +$65.1K 0.52% 48
2019
Q4
$11.4M Sell
47,210
-1,691
-3% -$373K 0.51% 52
2019
Q3
$9.46M Buy
48,901
+45,183
+1,215% +$8.67M 0.46% 57
2019
Q2
$685K Buy
3,718
+145
+4% +$26K 0.04% 209
2019
Q1
$679K Buy
3,573
+16
+0.4% +$3.06K 0.04% 161
2018
Q4
$692K Buy
3,557
+72
+2% +$14K 0.04% 156
2018
Q3
$722K Sell
3,485
-234
-6% -$46.1K 0.04% 176
2018
Q2
$686K Buy
3,719
+216
+6% +$38.2K 0.04% 177
2018
Q1
$597K Sell
3,503
-12
-0.3% -$2.2K 0.03% 167
2017
Q4
$611K Sell
3,515
-831
-19% -$147K 0.04% 161
2017
Q3
$810K Sell
4,346
-39,786
-90% -$7.05M 0.05% 137
2017
Q2
$7.6M Buy
44,132
+2,407
+6% +$391K 0.53% 28
2017
Q1
$6.85M Buy
41,725
+3,178
+8% +$528K 0.52% 30
2016
Q4
$5.64M Buy
38,547
+7,808
+25% +$1.18M 0.49% 46
2016
Q3
$5.13M Buy
30,739
+537
+2% +$90.8K 0.5% 36
2016
Q2
$4.59M Buy
30,202
+3,801
+14% +$591K 0.5% 40
2016
Q1
$3.96M Buy
26,401
+1,280
+5% +$190K 0.49% 53
2015
Q4
$4.08M Buy
25,121
+21,130
+529% +$3.32M 0.54% 29
2015
Q3
$552K Sell
3,991
-71
-2% -$11.2K 0.08% 115
2015
Q2
$624K Buy
4,062
+133
+3% +$21.3K 0.09% 114
2015
Q1
$628K Buy
3,929
+81
+2% +$12.8K 0.09% 116
2014
Q4
$613K Hold
3,848
0.1% 112
2014
Q3
$540K Sell
3,848
-956
-20% -$125K 0.1% 121
2014
Q2
$569K Buy
4,804
+4,783
+22,776% +$554K 0.11% 115
2014
Q1
$3K Sell
21
-13
-38% -$1.58K ﹤0.01% 420
2013
Q4
$4K Hold
34
﹤0.01% 448
2013
Q3
$4K Hold
34
﹤0.01% 346
2013
Q2
$3K Buy
+34
New +$3.53K ﹤0.01% 333

Other funds holding AMGN

Gradient Investments's AMGN Position: Q2 2026 in Review

Gradient Investments increased its Amgen (AMGN) stake by 1.4% in Q2 2026, buying an estimated $216K and bringing the position to 45,254 shares worth $16.4M. The position accounts for 0.23% of the portfolio, ranked #130.

Gradient Investments first reported a position in AMGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $18M in Q4 2023. 1,183 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Gradient Investments held 45,254 shares of Amgen worth $16.4M as of Q2 2026.
  • Gradient Investments bought 631 Amgen shares in Q2 2026, an estimated $216K.
  • Amgen made up 0.23% of Gradient Investments's portfolio in Q2 2026, its #130 holding.
  • Gradient Investments first reported a position in Amgen in Q2 2013 and has held it in 53 quarters since.
  • Gradient Investments's Amgen position peaked at $18M in Q4 2023.
  • 1,183 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Gradient Investments's 13F filing for Q2 2026, filed 8 Jul 2026.